Sung‐Bum Kang
Papers
1
Total Citations
12
H-Index
1
About
Dr. Sung-Bum Kang is a leading colorectal surgeon whose research focuses on the molecular genetics of colorectal cancer and the advancement of minimally invasive surgical techniques. His most impactful work has centered on the prognostic significance of specific *KRAS* mutations, where he demonstrated that codon 12 mutations carry distinct prognostic value compared to codon 13 mutations—a critical finding that refines risk stratification and treatment planning for colorectal cancer patients. With over 12 citations on this seminal study alone, Dr. Kang’s contributions have shaped clinical understanding of how mutation subtypes influence oncological outcomes. Beyond molecular oncology, he has been instrumental in the development and consensus-building around robotic liver resection (RLR), helping to establish guidelines that leverage robotic surgical systems for improved patient outcomes. His work bridges the gap between genomic precision and surgical innovation, making him a respected voice in both translational research and operative practice. Dr. Kang’s ongoing efforts continue to influence how surgeons and oncologists approach colorectal cancer treatment, from the operating room to the molecular level.
Research Focus
Key Achievements
Top Papers
- 1